Statement for gastroesophageal reflux disease after peroral endoscopic myotomy from an international multicenter experience
Publication Date
1-1-2020
Document Type
Article
Publication Title
Esophagus
Abstract
It has been 10 years since peroral endoscopic myotomy (POEM) was reported for the first time, and POEM has currently become the standard treatment for achalasia and related disorders globally because it is less invasive and has a higher curative effect than conventional therapeutic methods. However, there are limited studies comparing the long-term outcomes of POEM with those of conventional therapeutic methods, particularly in the occurrence of gastroesophageal reflux disease (GERD) after therapy. With this background, we held a consensus meeting to discuss the pathophysiology and management of GERD after POEM based on published papers and experiences of each expert and to discuss the prevention of GERD and dealing with anti-acid drug refractory GERD. This meeting was held on April 27, 2018 in Tokyo to establish statements and finalize the recommendations using the modified Delphi method. This manuscript presents eight statements regarding GERD after POEM.
First Page
3
Last Page
10
APA Citation
Inoue, H., Shiwaku, H., Kobayashi, Y., Chiu, P., Hawes, R., Neuhaus, H., Costamagna, G., Stavropoulos, S., Fukami, N., Seewald, S., Onimaru, M., Minami, H., Tanaka, S., Shimamura, Y., Santi, E., Grimes, K., & Tajiri, H. (2020). Statement for gastroesophageal reflux disease after peroral endoscopic myotomy from an international multicenter experience. Esophagus, 17(1), 3-10. https://doi.org/10.1007/s10388-019-00689-6